Follow-On Biologics: Defeat For Waxman, Win For Health Reform
Executive Summary
Rep. Henry Waxman, D-Calif., can perhaps take some comfort in the fact that his defeat on follow-on biologics means his broader health reform legislation may have a greater chance of passage
You may also be interested in...
PhRMA Donations To Political Campaigns Reflect Makeup Of Congress, Group Says
The skewing of the Pharmaceutical Research and Manufacturers of America’s PAC political campaign donations in favor of Democrats reflects the current makeup of Congress rather than an attempt to influence the outcome of the 2010 midterm elections, the organization maintains.
PhRMA Donations To Political Campaigns Reflect Makeup Of Congress, Group Says
The skewing of the Pharmaceutical Research and Manufacturers of America’s PAC political campaign donations in favor of Democrats reflects the current makeup of Congress rather than an attempt to influence the outcome of the 2010 midterm elections, the organization maintains.
Many Blue Dogs Go Against House Bill Despite Concessions On Public Option
Blue Dog Democrats' "no" votes make House health reform vote a close one: Could more conservative Senate Finance Committee bill be ultimate template for reform?